Japan· JP-4291425D1021
ブレンツキシマブ ベドチン（遺伝子組換え）
A medicinal product containing ブレンツキシマブ ベドチン（遺伝子組換え）, registered in Japan by 武田薬品工業, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ブレンツキシマブ ベドチン（遺伝子組換え）
- Manufacturer
- 武田薬品工業
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ブレンツキシマブ ベドチン（遺伝子組換え） in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandADCETRIS2care4 ApS
- SwitzerlandAdcetris
- SpainADCETRIS 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONTakeda Pharma A/S
- FranceADCETRIS 50 mg, poudre pour solution à diluer pour perfusionTAKEDA PHARMA (DANEMARK)
- United KingdomAdcetris 50mg powder for concentrate for solution for infusion vialsTakeda UK Ltd
- IrelandADCETRIS 50 mg powder for concentrate for solution for infusionTakeda Pharma A/S
- IcelandADCETRISTakeda Pharma A/S
- NetherlandsAdcetris 50 mg, poeder voor concentraat voor oplossing voor infusieTakeda Pharma A/S
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Adcetris
- Liechtenstein · Adcetris
- Norway · Adcetris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/58527d6b-27c0-4130-81f6-820a2bfe2f7f GET /v1/drugs/58527d6b-27c0-4130-81f6-820a2bfe2f7f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "５０ｍｇ１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "4291425D1021",
"category": "注射薬",
"price_yen": 388958,
"generic_name": "ブレンツキシマブ ベドチン（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "4291",
"transitional_expiry": null
}See everything about ブレンツキシマブ ベドチン（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.